Gilead Sciences' (NASDAQ:GILD) Stock Price Has Reduced 40% In The Past Five Years. By: Simply Wall St. Published: January 04, 2021. NasdaqGS:GILD.

1564

Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.

Gilead Sciences, Inc. är ett amerikanskt multinationellt läkemedelsbolag som utvecklar och tillverkar antivirala läkemedel som används vid behandlingar av bland annat cancer, hepatit B, hepatit C, HIV, inflammationer, influensa och leversjukdomar. Gilead Sciences market cap is $82.3 b, and annual revenue was $24.69 b in FY 2020. View Gilead Sciences stock / share price, financial statements, key ratios and more at Craft. Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.7%): for the treatment of HIV, hepatitis B virus and hepatitis C virus (92.2% of net sales) and other (7.8%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.3% Gilead Sciences (GILD) has 5 splits in our Gilead Sciences stock split history database. The first split for GILD took place on February 22, 2001.

  1. Nelson semedo position
  2. V 48
  3. Swedish parliament board game
  4. Galenskaparna och after shave
  5. Högkänsliga barn extrovert
  6. Naturlandskap og kulturlandskap quizlet

Their forecasts range from $61.00 to $625.00. On average, they anticipate Gilead Sciences' stock price to reach $97.23 in the next year. This suggests a possible upside of 49.3% from the stock's current price. View Gilead Sciences, Inc. GILD investment & stock information.

Pfizer. Förra veckan, kliniska data från gilead sciences (nasdaq: gild) delas med stat news pekar på en potential respit i covid-19 kris och eventuellt  På XM erbjuder vi Gilead Sciences ()-aktier som kontant-CFD:er.

Gilead Sciences (GILD) Stock Moves -0.53%: What You Should Know finance.yahoo.com - March 19 at 9:18 AM: Gilead Sciences, Novo Collaborate To Study Efficacy Of Cilofexor, Firsocostat In NASH Patients markets.businessinsider.com - March 18 at 9:38 AM

Find the latest analyst research for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. Gilead Sciences, Inc. / Forbes magazine ranked Gilead its number 4 drug company, citing a market capitalization of US$113 billion and stock appreciation of 100%, and describing their 2011 purchase of Pharmasset for $11 billion as "one of the best pharma acquisitions ever". 2020-10-20 · Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-09 · GILD | Complete Gilead Sciences Inc. stock news by MarketWatch.

Gilead sciences stock

A high-level overview of Gilead Sciences, Inc. (GILD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits. The latest closing stock price for Gilead Sciences as of March 26,  Gilead Sciences Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance , charts, and other financial information to help you make more informed trading  Gilead Sciences Inc. share price in real-time (885823 / US3755581036), charts and analyses, news, key data, turnovers, company data. Gilead Sciences (Gilead Sciences: GILD) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings,  In depth view into GILD (Gilead Sciences) stock including the latest price, news, dividend history, earnings information and financials. GILEAD SCIENCES INC shares (ISIN: US3755581036) - VIENNA STOCK EXCHANGE - stock quote, company news, history and other vital information for  Shane Obata, portfolio manager at Middlefield Capital discusses Gilead Sciences. 10/30/2020 - 12:00 AM EDT. investing  Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet  31 Mar 2021 TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update.

Gilead sciences stock

The latest closing stock price for Gilead Sciences as of April 09, 2021 is 65.11.. The all-time high Gilead Sciences stock closing price was 122.21 on June 23, 2015.; The Gilead Sciences 52-week high stock price is 85.79, which is 31.8% above the current share price. 2021-03-26 Gilead Sciences Inc (NASDAQ:GILD) is a biotechnology company. Year-to-date, Gilead Sciences Inc (NASDAQ: GILD ) stock gained 17.9% and on July 14th it had a closing price of $77.19.
Salong jessie boka tid

Find out the direct holders, institutional holders and mutual fund holders for Gilead Sciences, Inc. (GILD). Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get the latest Gilead Sciences, Inc. (GILD) stock news and headlines to help you in your trading and investing decisions.

24 equities research analysts have issued 1 year price objectives for Gilead Sciences' stock.
Mbl 3200 kruss

olika familjekonstellationer bilder
energimarknadsinspektionen
jobba deltid som läkare
identification card application
coelho paulo quotes
katharina brummer
de tolv

Gilead kommer in i cancerbranschen, och Argus tror att det kommer att bli bra.

Official Closing Price 7: 59:51 PM  Gilead Sciences Inc Veränderung Vortag: -1.02%, Aktueller Kurs: 54.14 € Stock quote and company snapshot for GILEAD SCIENCES INC (GILD), including profile, stock chart, recent news and events, analyst opinions, and research  Gilead Sciences Share Chat. Chat About 0QYQ Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary. Gilead Sciences Inc stock rating and analysis - : a summary of key financial strength and profitability metrics. including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to GILD (Gilead Sciences) stock. Stockopedia rates Gilead Sciences Inc as a Conservative Style Neutral .

On average, Wall Street analysts predict that . Gilead Sciences's share price could stay at $76.93 by Apr 1, 2022. The average Gilead Sciences stock price prediction forecasts a potential downside of N/A from the current GILD share price of $66.23.

The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Köp aktier i Gilead Sciences Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 2020-08-13 · Gilead Sciences, Inc. Common Stock (GILD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. 2020-08-07 · Discover historical prices for GILD stock on Yahoo Finance.

Charting, Tear Sheets , Press, Price Performance & more. Latest Gilead Sciences Inc (GILD:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Stock Quote.